You guys know I love biotechs with press releases coming up. I also like to wait to enter until the charts look bullish. Aquestive Therapeutics fell from $8 to $4 in September 2020, and I think they could pull back eventually, regardless of press releases. Now that they have an approval coming up on the second, I expect them to perform phenomenally for the rest of February. They may even push all the way back up to $8. I chose to post now because they look very bullish, at the bottom of the RSI and the MACD looks like it may cross soon. Good Luck!